Enter your login e-mail to the account
Search
Search parameters
Search results
- Inhibition ALK and ROS1 in the treatment of metastatic non-small lung cancer – new treatment options and recommendations
MUDr. Lucia Denková
(1/2021, Main topic ) - Chromosomal rearrangements in lung adenocarcinoma – new treatment options
RNDr. Katarína Hlinková
(3/2014, Review articles ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Clinical significance of PD-L1 immune check-point measurement
MUDr. Peter Kasan
(2/2017, Drugs & drug classes ) - Targeted treatment of non-small cell lung cancer – update
MUDr. Gabriela Chowaniecová, prof. MUDr. Dalibor Ondruš, DrSc.
(4/2022, Review articles ) - Comprehensive analysis of selected epidemiological indicators of lung cancer in the Slovak Republic in an interactive online environment
doc. RNDr. Martina Ondrušová, PhD., MPH, Ing. Martin Suchanský
(6/2021, Main topic ) - Testing molecular biomarkers in the treatment and management of patients with lung cancer in Slovakia
RNDr. Regína Lohajová Behulová, PhD., RNDr. Romana Valenčíková, PhD., Dr. Med. Veronika Urbán
(S2/2023, Review articles ) - Správa z Best of ASCO® Slovakia 2012
MUDr. Mária Rečková
(6/2012, Events ) - Actual therapeutic strategy of patients with non small cell lung cancer with EML4-ALK rearrangement
MUDr. Juraj Mazal, MUDr. Michal Urda, RNDr. Anna Farkašová, PhD.
(1/2017, Review articles ) - Systemic treatment of metastatic renal cell carcinoma after failure of the first line of treatment
MUDr. Dagmar Sudeková
(1/2018, Main topic )
- Contemporary approaches to genetic diagnostics in clinical oncology
RNDr. Regína Lohajová Behulová, PhD., Mgr. Michal Svoboda, RNDr. Aster Alemayehu, PhD., Mgr. Lukáš Šebest, PhD.
(2/2024, Main topic )